期刊文献+

心脏再同步治疗慢性心力衰竭患者细胞因子浓度变化及其与左室射血分数的关系

Cytokines level in chronic heart failure patients receiving cardiac resynchronization therapy and its relationship with left ventricular ejection fraction
暂未订购
导出
摘要 目的探讨心脏再同步治疗(CRT)1个月、3个月对慢性心力衰竭患者血清细胞因子水平的影响及其与左室射血分数(LVEF)的关系。方法入选心功能Ⅲ~Ⅳ级的患者30例,分为CRT组15例,对照组15例。两组于治疗前、治疗后1个月及3个月分别测定肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)浓度,超声测量LVEF。结果CRT组治疗3个月后TNF-α、IL-6浓度与治疗前相比明显下降。治疗后1个月及3个月,CRT组LVEF均较治疗前明显改善。细胞因子(TNF-α、IL-6)浓度与LVEF呈显著负相关。结论CRT治疗3个月后心功能改善的同时细胞因子浓度降低,提示血清TNF-α、IL-6浓度可作为慢性心力衰竭患者心功能的预测指标。 Objective To investigate the changes of serum cytokines in chronic heart failure (CHF) patients who received cardiac resynchronization therapy for 1 and 3 months and its relationship with left ventricular ejection fraction (LVEF).Methods Thirty CHF patients with New York Heart Association (NYHA) classⅢor Ⅳwere selected. Fifteen patients received biventricular pacing therapy (CRT group) and the other 15 patients received optimal medical therapy (control group). The LVEF and serum levels of TNF-α and IL-6 were determined before treatment,at 1,3 months after treatment respectively.Results The serum TNF-α and IL-6 concentrations were decreased significantly after 3 months of CRT treatment,and LVEF was improved remarkably after 1 and 3 months of CRT treatment. The serum cytokines (TNF-α and IL-6) level had a significant negative correlation with LVEF. Conclusion After 3 months of CRT treatment,the heart function is improved,and serum cytokines(TNF-α,IL-6) concentrations are decreased. It indicates that serum level of TNF-α and IL-6 may have predictive value for the heart function of patients with CHF.
出处 《中华老年多器官疾病杂志》 2010年第1期41-43,共3页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 心力衰竭 细胞因子类 心脏再同步治疗 heart failure cytokines cardiac resynchronization therapy
  • 相关文献

参考文献5

  • 1Ferreira A.Cytokines in heart failure[J].Rev Port Cardiol,2004,23(2):121-127.
  • 2Salukhe TV,Dimopoulos K,Francis D.Cardiac resynchronisation may reduce all-cause mortality:metaanalysis of preliminary COMPANION data with CONTAK-CD,InSync ICD,MIRACLE and MUSTIC[J].Int J Cardiol,2004,93(2-3):101-103.
  • 3Hirota H,Izumi M,Hamaguchi T,et al.Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure[J].Heart Vessels,2004,19(5):237-241.
  • 4孟繁波,辛暨华,辛华,郑雅娟,王维忠.心力衰竭与细胞因子的关系及治疗新对策[J].中国免疫学杂志,2002,18(12):875-879. 被引量:4
  • 5Pan JP,Liu TY,Chiang SC,et al.The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure[J].J Chin Med Assoc,2004,67(5):222-228.

二级参考文献27

  • 1[1]Levine B, Kalman J, Mayer L et al. Elevated circulating levels of tumor necrosis factor in congestive heart failure[J]. N Engl J Med, 1990;323:236
  • 2[2]Bryant D, Becker L, Richardson J et al. Cardiac failure in transgenic mice with myocardial expression of tunnor necrosis factor-alpha[J] .Circulation,1998;97:1375
  • 3[3]Kapadia S,Torre A G, Yokoyama T et al. Soluble TNF binding roteins modulate the negative inotropic properties of TNF-α in vitro [ J ]. Am J Physiol, 1995 ;268:H517
  • 4[4]AbrahamE,CoulsonWF,SchwartzMDetal. Effect of therapy with soluble tumor necrosis factor receptor fusion protein on pulmonary cytokine expression and lung injury following hemorrage and resuscitstion[J]. Clin Exp Immuno, 1994;98:29
  • 5[5]Diez R A,Tile G P, Zangerle R et al. Soluble reesptors for tumor necrosis factor in clinical laboratory diagnois[J].Eur J Haematd, 1995;54:1
  • 6[6]J Koller-Strametz,Packer R, Frey B et al. Circulating tumor necrosis factor-alpha levels in chronic heart failure:relation to its soluble receptor Ⅱ,interleukin-6 and neurohornmonal variables[J]. J Heart Lung Transplant,1998;17:356
  • 7[7]Parissis J, Venetsanon K,Mentzkof D et al. Clinical relevance of cytokine receptor soluble forms in decompensated advanced hesrt failure[J]. Eur Heart J, 1998; 19(suppl) :2661
  • 8[8]Paulus W J.How are cytokine activated in heart failure[J]? F ur J Heart Fail, 1999; 1:309
  • 9[9]Suzuki K,Murtuza B,FRCS M A et al. Overexpression of interleukine-2receptor antagonst provides cardlioprotection against ischemia reperfusion injury associated with reduction in apoptosis[J]. Circulation, 2001; 104:(12)1308
  • 10[10]MarriotJB,GddmanJH,KeelingPJ et al. Abnonnal cytokine profiles in patients with idiopathic dilated cardomyopathy and their asymptomatic relatives[J]. Heart, 1996;75:287

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部